ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,874Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 103

$429K Total Retail Price of All Prescriptions

Rank: 45 out of 103

254 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 254 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 254 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 357 310 1 3
AMLODIPINE BESYLATE 297 243 2 6
LEVOTHYROXINE SODIUM 287 268 3 1
LISINOPRIL 258 208 4 5
SIMVASTATIN 251 209 5 2
METFORMIN HCL 190 161 6 13
LOSARTAN POTASSIUM 190 155 6 12
HYDROCHLOROTHIAZIDE 188 178 8 16
METOPROLOL TARTRATE 159 136 9 9
CARVEDILOL 145 120 10 20
ATENOLOL 141 97 11 14
CRESTOR 135 120 12 27
FUROSEMIDE 128 118 13 4
EVISTA 117 116 14 117
ATORVASTATIN CALCIUM 108 107 15 18
LOSARTAN-HYDROCHLOROTHIAZIDE 102 90 16 47
PRAVASTATIN SODIUM 90 84 17 33
ZOLPIDEM TARTRATE 88 67 18 29
SERTRALINE HCL 83 58 19 21
JANTOVEN 83 76 19 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 70 21 48
ALENDRONATE SODIUM 77 76 22 19
MELOXICAM 77 69 22 49
POTASSIUM CHLORIDE 73 66 24 10
GLIPIZIDE 68 41 25 65
LOVASTATIN 67 67 26 67
SPIRONOLACTONE 66 51 27 30
DIOVAN 66 66 27 40
HYDROCODONE-ACETAMINOPHEN 65 37 S3 29 11
CITALOPRAM HBR 63 51 30 15
AMITRIPTYLINE HCL 62 61 R 31 54
CELEBREX 59 57 32 137
PAROXETINE HCL 55 38 33 81
BENAZEPRIL HCL 55 55 33 93
METOPROLOL SUCCINATE 54 54 35 8
ENALAPRIL MALEATE 53 41 36 63
PREDNISONE 53 41 36 24
ALLOPURINOL 52 45 38 26
OXYCODONE-ACETAMINOPHEN 50 23 S2 39 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.